Mouse/Rat Hypoxia Serum/Plasma Kit

Application(s)		Hypoxia , Cardiovascular
Analyte(s)		EPO, VEGF-A
Species		Mouse, Rat
Instrument(s)		SECTOR Imager 2400 , SECTOR Imager 6000 , MESO QuickPlex SQ 120 , MESO QuickPlex SQ 120MM , MESO SECTOR S 600 , MESO SECTOR S 600MM
Plate Type		96-well
Capture Antibody		EPO: Mouse monoclonal VEGF: Goat Polyclonal
Detection Antibody		EPO: Mouse monoclonal VEGF: Goat Polyclonal
LLOD (Sensitivity)		Depending on the desired application, the protocol can be applied to mouse or rat calibrators. Mouse EPO: 2.3 pg/mL Rat EPO: 2.0 pg/mL Mouse VEGF: 1.8 pg/mL Rat VEGF: 19 pg/mL
Dynamic Range		Depending on the desired application, the protocol can be applied to mouse or rat calibrators. Mouse EPO: 2.3-10000 pg/mL Rat EPO: 2.0-10000 pg/mL Mouse VEGF: 1.8-10000 pg/mL Rat VEGF: 19-10000 pg/mL
Sample Type		Serum, Plasma
Recombinant standards		Mouse EPO: Recombinant protein expressed in mouse myeloma cell line, NSO Rat EPO: Recombinant protein expressed in insect cell line Mouse VEGF: Recombinant protein expressed in insect cells Rat VEGF: Recombinant protein expressed in mouse myeloma cell line, NSO
Usage Statement		For Research Use Only. Not for use in diagnostic procedures.
Storage Statement(s)		Please refer to the product insert for the storage conditions of individual kit components.
Storage Condition		Multi-Component

Product Inserts		Mouse Rat Hypoxia Serum
Datasheets		DS Mouse Rat Hypoxia Serum
SDS		Blocker A Diluent 10, Diluent 11, Diluent 12, Diluent 13, Diluent 15, Diluent 16 and Diluent 17 Diluent 2, Diluent 3, Diluent 5, Diluent 7 and Diluent 8 MSD Calibrators and Controls Phosphate Buffer (5x) Read Buffer T (4x), Read Buffer S (4x) and Read Buffer S (1x)

Title	Journal	Year
Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection Najmeh Bozorgmehr, Siavash Mashhouri, Eliana Perez Rosero, Lai Xu, Shima Shahbaz, Wendy Sligl, Mohammed Osman, Demetrios J. Kutsogiannis, Erika MacIntyre, Conar R. O’Neil, Shokrollah Elahi	mBio	2021
Biomarkers of Tuberculosis Severity and Treatment Effect: A Directed Screen of 70 Host Markers in a Randomized Clinical Trial G B Sigal, M R Segal, A Mathew, L Jarlsberg, M Wang, S Barbero, N Small, K Haynesworth, J L Davis, M Weiner, W C Whitworth, J Jacobs, J Schorey, D M Lewinsohn, P Nahid	EBioMedicine	2017
A hepcidin lowering agent mobilizes iron for incorporation into red blood cells in an adenine-induced kidney disease model of anemia in rats. Sun CC, Vaja V, Chen S, Theurl I, Stepanek A, Brown DE, Cappellini MD, Weiss G, Hong CC, Lin HY, Babitt JL.	Nephrol Dial Transplant	2013
Experimental pain and opioid analgesia in volunteers at high risk for obstructive sleep apnea Doufas AG, Tian L, Padrez KA, Suwanprathes P, Cardell JA, Maecker HT, Panousis P.	PLoS One	2013
Controlled regulation of erythropoietin by primary cultured renal cells for renal failure induced anemia. Gyabaah K, Aboushwareb T, Guimaraes Souza N, Yamaleyeva L, Varner A, Wang HJ, Atala A, Yoo JJ.	J Urol.	2012
View All

Please Sign In